The Medical University of South Carolina is welcoming volunteers to join their study in creating a COVID-19 antibody treatment. Their ideal test subjects are folks who have previously tested positive for Coronavirus, while not needing to be hospitalized. This SC study is solely available by the providers at MUSC.
As for details of the research itself, some participants will receive a supplement of SARS-CoV-2 monoclonal antibodies, while others will receive a placebo. Trial manager Amanda Cameron believes they won’t have any trouble finding volunteers for such a study. “Our previous COVID inpatient studies all enrolled much faster than anticipated because the spread has been so significant.”
As SC case numbers climb to over 91,788, it’s likely they’ll have a large pool of people to select from. The funding for the MUSC research comes directly from the federal government’s $450 million contract with Regeneron. If successful, the Food and Drug Administration has given the okay for its future treatment.
MUSC plans to carefully select their participants in order to achieve the most accurate results. The screening process will be quite selective as the search for a COVID-19 treatment continues.